Image may be NSFW.
Clik here to view.
Clik here to view.
Amgen in $180.5 Million Drug Development Deal with BIND Biosciences
Catherine Arnst Cambridge, MA-based BIND Biosciences got a large vote of confidence today for its novel targeted nanomedicine technology. The startup announced today that Amgen (NASDAQ: AMGN), in...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
East Coast Life Sciences Roundup: Bind, Boston Children’s, J&J, More
Catherine Arnst The life sciences industry was focused on the west coast, not the east, this week. Virtually all of the industry’s movers, shakers, and wannabes were at the 31st Annual JP Morgan...
View Article
More Pages to Explore .....
